All posts tagged "CYDY"

• 

  1.2K

  2

  Biotech

  CytoDyn’s Preliminary Phase 1b/2 Cancer Results Likely to Receive Breakthrough Therapy Designation (BTD)

  CytoDyn Inc. (OTCMKTS: CYDY) announced excellent preliminary results from its Phase 1b/2 clinical trial in metastatic triple negative breast cancer (mTNBC) that...

• 

  3.1K

  Biotech

  Enzolytics (ENZC) Working With Intel (INTC)

  Intel whitepaper highlights case study on Enzolytics COVID-19 and HIV potential for neutralization of both viruses. Bear case is nothing but FUD....

• 

  1.5K

  Biotech

  CytoDyn FDA Letter is Old News – International Still Progressing

  CytoDyn Inc (OTCMKTS: CYDY) shareholders got a real gut check yesterday as the STAT writer Adam Feuerstein sent out a tweet at...

• 

  1.9K

  Biotech

  CytoDyn’s Adjust Course to Emphasize Philippine EUA and Long Haulers

  Many CytoDyn Inc. (OTCMKTS: CYDY) shareholders have been waiting impatiently for an EUA from the US FDA and a BLA in HIV. ...

• 

  2.2K

  Biotech

  CytoDyn Doubles Down on Revenue and EUA Strategy with Philippines Announcement

  CytoDyn Inc. (OTCMKTS: CYDY) announced yesterday that it shipped 28 doses of leronlimab under Compassionate Special Permit (CSP) to one hospital in...

• 

  2.4K

  Momentum & Growth

  OTC Markets Update: CYDY EEENF ENZC OPTI

  We are starting to see some stability in the OTC Markets. The last few weeks have been hard on many OTC traders...

• 

  1.8K

  Biotech

  COVID Stocks Popping in Sympathy with Positive Humanigen Top Line Data

  Humanigen Inc. (NASDAQ: HGEN) released excellent news that their drug lenzilumab improved survival without the need for invasive mechanical ventilation (IMV) by...

• 

  2.4K

  1

  Biotech

  CytoDyn’s Smoking Gun For an Immediate EUA

  The controversy surrounding CytoDyn Inc. (OTCMKTS: CYDY) stock is startling.  An aggressive pack of  short sellers claim its leronlimab Covid trial  didn’t...

• 

  3.0K

  3

  Biotech

  CytoDyn Saves Lives & Reduces COVID-19 Hospital Duration

  6 endpoints met after full data release so shorts double down on trial failure narrative  Investors in CytoDyn Inc. (OTCMKTS: CYDY) are...

• 

  15.8K

  6

  Biotech

  Leronlimab Trial Results All But Certain Pointing to Approval For CytoDyn

  CytoDyn Inc. (OTMKTS: CYDY) announced discussions with 3 regulatory agencies after an unblinding of the data on February 22, 2021, and the...